Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 2 Spondylitis, Ankylosing 1 Signs and Symptoms 1 Psoriasis 1 Nutrition Disorders 1 Lymphoma 1 Leukemia, Myeloid, Acute 1 Insulin Resistance 1 Inflammatory Bowel Diseases 1 Glioma 1 Gastroparesis 1 Feeding and Eating Disorders 1 Esophageal Neoplasms 1 Epilepsy 1 Dumping Syndrome 1 Diarrhea 1 Colorectal Neoplasms 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

Temozolomide 109 Magnetic Resonance Spectroscopy 52 Bevacizumab 52 Radiotherapy 44 Irinotecan 27 Blood Specimen Collection 19 Surgical Procedures, Operative 16 Radiation 15 Aminolevulinic Acid 15 Carboplatin 13 fluorodopa F 18 12 Nivolumab 12 Radiotherapy, Intensity-Modulated 11 Carmustine 11 Radiosurgery 10 Magnetic Resonance Imaging 10 pembrolizumab 9 Topotecan 9 Specimen Handling 9 Everolimus 9 Erlotinib Hydrochloride 9 Biopsy 9 poly ICLC 8 Surveys and Questionnaires 8 Standard of Care 8 Etoposide 8 Drug Therapy 8 Filgrastim 7 Cyclophosphamide 7 ribociclib 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Glioma × Sulfasalazine × Clear all

NCT04205357 2023-03-03

SAS-GKRS

Haukeland University Hospital

Phase 1 Completed

Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡